Career
In 2002, Enitan was granted a patent by the United States government after he produced a formulation that would prevent muscle atrophy in Acquired Immune Deficiency Syndrome and cancer patients.
In 2002, Enitan was granted a patent by the United States government after he produced a formulation that would prevent muscle atrophy in Acquired Immune Deficiency Syndrome and cancer patients.
